Compare Stocks

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DADA Dada Nexus	$2.00 +7.5%	$2.16	$1.36 ▼ $7.03	$524.02M	1.5	3.13 million shs	1.43 million shs
FDS FactSet Research Systems	$422.83 +0.7%	$452.19	$380.96 ▼ $488.64	$16.12B	0.72	242,859 shs	294,688 shs
GDS GDS	$7.26 +7.2%	$7.01	$5.01 ▼ $15.75	$1.29B	0.4	1.78 million shs	1.76 million shs
LN LINE	$51.98	$51.98	$44.43 ▼ $53.62	$12.52B	0.58	30,003 shs	N/A
LVGO Livongo Health	$139.77	$140.45	$18.76 ▼ $151.05	$14.20B	1.81	3.04 million shs	N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DADA Dada Nexus	+7.53%	+9.29%	-20.95%	-3.85%	-64.97%
FDS FactSet Research Systems	+0.67%	-1.50%	-4.96%	-10.25%	+2.61%
GDS GDS	+7.24%	+16.16%	-13.26%	+22.22%	-50.98%
LN LINE	0.00%	0.00%	0.00%	0.00%	0.00%
LVGO Livongo Health	0.00%	0.00%	0.00%	0.00%	0.00%

Just Released: Insider's Secret to Trading Options (Ad)

This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.

Yes! Show Me This Strategy

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DADA Dada Nexus	2.8813 of 5 stars	3.2	3.0	0.0	0.0	2.0	0.8	2.5
FDS FactSet Research Systems	4.3591 of 5 stars	1.9	2.0	3.3	3.9	2.4	2.5	2.5
GDS GDS	0.957 of 5 stars	3.3	1.0	0.0	0.0	1.2	0.0	1.3
LN LINE	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LVGO Livongo Health	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DADA Dada Nexus	2.43	Hold	$6.00	199.86% Upside
FDS FactSet Research Systems	1.73	Reduce	$442.70	4.70% Upside
GDS GDS	2.60	Moderate Buy	$15.69	116.08% Upside
LN LINE	N/A	N/A	N/A	N/A
LVGO Livongo Health	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest LN, DADA, FDS, GDS, and LVGO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/11/2024	FDS FactSet Research Systems	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Underperform	$430.00
3/28/2024	GDS GDS	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$12.00 ➝ $7.00
3/25/2024	FDS FactSet Research Systems	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$447.00 ➝ $458.00
3/22/2024	FDS FactSet Research Systems	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$469.00
3/22/2024	FDS FactSet Research Systems	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sell ➝ Sell	$377.00 ➝ $419.00
3/22/2024	FDS FactSet Research Systems	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$464.00
3/22/2024	FDS FactSet Research Systems	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
3/22/2024	FDS FactSet Research Systems	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$480.00 ➝ $460.00
3/6/2024	DADA Dada Nexus	New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$15.00 ➝ $2.00
2/20/2024	DADA Dada Nexus	Daiwa Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$3.50

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DADA Dada Nexus	$1.49B	0.35	N/A	N/A	$3.00 per share	0.67
FDS FactSet Research Systems	$2.09B	7.73	$17.79 per share	23.77	$47.27 per share	8.94
GDS GDS	$9.80B	0.14	$1.43 per share	5.06	$14.09 per share	0.52
LN LINE	$2.12B	5.91	N/A	N/A	$6.67 per share	7.79
LVGO Livongo Health	$170.20M	83.42	N/A	N/A	$5.37 per share	26.03

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DADA Dada Nexus	-$276.60M	-$1.31	N/A	4.44	N/A	-22.62%	-14.06%	-11.04%	5/8/2024 (Estimated)
FDS FactSet Research Systems	$468.17M	$12.63	33.48	24.23	2.70	22.72%	34.36%	14.67%	6/27/2024 (Estimated)
GDS GDS	-$604.24M	-$3.34	N/A	N/A	N/A	-43.25%	-8.90%	-2.50%	5/23/2024 (Estimated)
LN LINE	-$431.37M	-$1.82	N/A	∞	N/A	-15.54%	-26.95%	-8.13%	N/A
LVGO Livongo Health	-$55.27M	-$1.01	N/A	1,397.70	N/A	-12.20%	0.29%	0.21%	N/A

Latest LN, DADA, FDS, GDS, and LVGO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
3/26/2024	Q4 2023	GDS GDS	-$0.39	-$0.62	-$0.23	$1.20	$363.21 million	$360.07 million
3/25/2024	Q4 2023	DADA Dada Nexus	-$0.01	-$0.10	-$0.09	$0.48	$436.80 million	$381.95 million
3/21/2024	Q2 2024	FDS FactSet Research Systems	$3.83	$4.22	+$0.39	$4.79	$547.93 million	$545.95 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DADA Dada Nexus	N/A	N/A	N/A	N/A	N/A
FDS FactSet Research Systems	$3.92	0.93%	+8.12%	31.04%	25 Years
GDS GDS	N/A	N/A	N/A	N/A	N/A
LN LINE	N/A	N/A	N/A	N/A	N/A
LVGO Livongo Health	N/A	N/A	N/A	N/A	N/A

Latest LN, DADA, FDS, GDS, and LVGO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/2/2024	FDS FactSet Research Systems	quarterly	$0.98	0.8%	2/28/2024	2/29/2024	3/21/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DADA Dada Nexus	N/A	3.04	3.03
FDS FactSet Research Systems	0.83	1.79	1.79
GDS GDS	1.92	1.32	1.52
LN LINE	N/A	0.85	0.82
LVGO Livongo Health	0.69	19.88	19.51

Ownership

Institutional Ownership

Company	Institutional Ownership
DADA Dada Nexus	59.25%
FDS FactSet Research Systems	91.24%
GDS GDS	33.71%
LN LINE	1.08%
LVGO Livongo Health	41.67%

Insider Ownership

Company	Insider Ownership
DADA Dada Nexus	8.50%
FDS FactSet Research Systems	1.00%
GDS GDS	7.99%
LN LINE	N/A
LVGO Livongo Health	13.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DADA Dada Nexus	2,631	262.01 million	239.74 million	Optionable
FDS FactSet Research Systems	12,237	38.12 million	37.74 million	Optionable
GDS GDS	2,185	190.55 million	175.33 million	Optionable
LN LINE	6,998	240.88 million	N/A	Optionable
LVGO Livongo Health	471	101.59 million	N/A	Not Optionable

LN, DADA, FDS, GDS, and LVGO Headlines

Source	Headline
	Diabetes management startup Clivi wants to be ‘Livongo of Latin America’ news.yahoo.com - June 20 at 12:48 PM
	Livongo raises funds for digital health platform pharmaphorum.com - March 15 at 7:35 PM
	9 Health and Nutrition Benefits of Apricots healthline.com - January 21 at 8:56 AM
	Salvo Health Secures $10.5 Million in Seed Funding To Scale Virtual Health Clinic for Chronic Conditions tmcnet.com - August 9 at 3:40 PM
	Down 87%, Could Teladoc Health Stock Actually Be A Buy? investing.com - August 1 at 12:48 PM
	Homeward partners with Rite Aid to deliver rural health care bizjournals.com - May 31 at 6:38 PM
	Dr. Kimon Angelides Announces Latest Venture, FemTec Health, a Health Sciences Company with a Mission to Transform Women’s Healthcare apnews.com - October 29 at 12:35 PM
	How to Capitalize on Volatile Markets elliottwave.com - August 3 at 12:21 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Dada Nexus

NASDAQ:DADA

Dada Nexus Limited operates a platform of local on-demand retail and delivery in the People's Republic of China. It operates Dada Now, a local on-demand delivery platform that provides intra-city delivery and last-mile delivery services on an on-demand basis to chain merchants, small- and medium-sized enterprise merchants, and individual senders; and JDDJ, a local on-demand retail platform for consumers, retailers, and brand owner. The company was incorporated in 2014 and is headquartered in Shanghai, the People's Republic of China.

FactSet Research Systems

NYSE:FDS

FactSet Research Systems Inc., a financial data company, provides integrated financial information and analytical applications to the investment community in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company delivers insight and information through the workflow solutions of research, analytics and trading, content and technology solutions, and wealth. It serves portfolio managers, investment banks, asset managers, wealth advisors, corporate clients, and other financial services entities. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut.

GDS

NASDAQ:GDS

GDS Holdings Limited, together with its subsidiaries, develops and operates data centers in the People's Republic of China. The company provides colocation services comprising critical facilities space, customer-available power, racks, and cooling; managed hosting services, including business continuity and disaster recovery, network management, data storage, system security, operating system, database, and server middleware services; managed cloud services; and consulting services. It serves cloud service providers, large Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. GDS Holdings Limited was founded in 2001 and is headquartered in Shanghai, the People's Republic of China.

LINE

NYSE:LN

LINE Corp. engages in the mobile communication business. It operates through the Core and Strategy segments. The Core segment handles advertising, communication, and content business. The Strategy segment includes FinTech services such as Line Pay. It also deals with artificial intelligence and e-commerce. The company was founded on September 4, 2000 and is headquartered in Tokyo, Japan.

Livongo Health

NASDAQ:LVGO

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial